Research into the efficacy and cost-effectiveness of brief, free of charge and anonymous sex counselling to improve (mental) health in youth: Design of a randomised controlled trial

Grauvogl, Andrea; Evers, Silvia M. A. A.; van den Hoek, Katy; van der Veen, Evert; Franke, Anja; van Lankveld, Jacques J. D. M.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p459
Academic Journal
Background: The capacity to form romantic relationships and sexual health of adolescents in the Netherlands are compromised by several factors, including young age of first intercourse and adolescent depression. Several thresholds like own expenses, trust and embarrassment prevent adolescents to seek help for their sexual problems. To overcome these thresholds, brief sex counselling has been developed. It has been used since 2006 within the Rotterdam-Rijnmond Public Health Service, but there is lack of information about the (cost-) effectiveness. In the current study we will evaluate the (cost-) effectiveness of brief sex counselling for sexual problems in adolescents and young adults between 18 and 25 years of age. Methods: In a randomised controlled trial we will compare (1) brief sex counselling with (2) intensive sexological treatment, and (3) delayed treatment (waiting list). Embedded in this RCT will be a trial-based economic evaluation, looking at the cost-effectiveness and cost-utility of brief sex counselling versus the two other interventions. Four hundred fifty adolescents (aged 18-25) with sexual problems will be recruited among the persons who visit the Public Health Service (PHS) and through various websites. After a screening procedure, eligible participants will be randomly allocated to one of the three intervention groups. Primary outcome measure of the clinical evaluation is the severity of sexual problems. Other outcomes include psychological distress, especially depression. The economic evaluation will be performed from a societal perspective. Costs will be assessed continuously by a retrospective questionnaire covering the last 3 month. All outcome assessments (including those for the economic evaluation) will take place via the internet at baseline, and at 3, 6, 9, and 12 months after baseline. Discussion: The proposed research project will be the first study to provide preliminary data about the effect and cost-effectiveness of brief sex counselling in youth in comparison with intensive sexological treatment and delayed treatment. It is anticipated that positive results in (cost-) effectiveness of the proposed intervention will contribute to the improvement of sexual health care for adolescents and young adults. Trial registration: The study has been registered at the Netherlands Trial Register, part of the Dutch Cochrane Centre (NTR1952)


Related Articles

  • Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectiveness. Briggs; Bower, Peter; Byford, Sarah; Sibbald, Bonnie; Ward, Elaine; King, Michael; Lloyd, Margaret; Gabbay, Mark // BMJ: British Medical Journal (International Edition);12/02/2000, Vol. 321 Issue 7273, p1389 

    Objective: To compare the cost effectiveness of general practitioner care and two general practice based psychological therapies for depressed patients.Design: Prospective, controlled trial with randomised and patient preference allocation arms.Setting: General practices in London and greater...

  • Developing stepped care treatment for depression (STEPS): study protocol for a pilot randomised controlled trial. Hill, Jacqueline J.; Kuyken, Willem; Richards, David A. // Trials;2014, Vol. 15 Issue 1, p2 

    Background Stepped care is recommended and implemented as a means to organise depression treatment. Compared with alternative systems, it is assumed to achieve equivalent clinical effects and greater efficiency. However, no trials have examined these assumptions. A fully powered trial of stepped...

  • Escitalopram ahead of the rest in MDD. Salmon, Kimberley // PharmacoEconomics & Outcomes News;7/2/2005, Issue 481, p3 

    Provides information on escitalopram, an enantiomer of the antidepressant citalopram, used for the treatment of major depressive disorder (MDD). Cost effectiveness of the drug; Clinical trial outcomes associated with escitalopram treatment of MDD; Response rates among primary care patients with...

  • Genetic testing before therapy may be worth it in severe MDD….  // PharmacoEconomics & Outcomes News;10/1/2011, Issue 638, p7 

    The article discusses a research study on the cost-effectiveness of performing a pharmocogenetic trial before commencing antidepressant treatment among selected groups of patients with severe and disabling major depressive disorder (MDD) in Italy. It references a study presented by P. Olgiati et...

  • Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Romeo, Renee; Knapp, Martin; Hellier, Jennifer; Dewey, Michael; Ballard, Clive; Baldwin, Robert; Bentham, Peter; Burns, Alistair; Fox, Chris; Holmes, Clive; Katona, Cornelius; Lawton, Claire; Lindesay, James; Livingston, Gill; McCrae, Niall; Moniz-Cook, Fsme; Murray, Joanna; Nurock, Shirley; O'Brien, John; Poppe, Michaela // British Journal of Psychiatry;Feb2013, Vol. 202 Issue 2, p121 

    Background: Depression is a common and costly comorbidity in dementia. There are very few data on the cost-effectiveness of antidepressants for depression in dementia and their effects on carer outcomes.Aims: To evaluate the cost-effectiveness of sertraline and...

  • Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial. de Graaf, L Esther; Gerhards, Sylvia A. H.; Evers, Silvia M. A. A.; Arntz, Arnoud; Riper, Heleen; Severens, Johan L.; Widdershoven, Guy; Metsemakers, Job F. M.; Huibers, Marcus J. H. // BMC Public Health;2008, Vol. 8 Issue 1, p224 

    Background: Major depression is a common mental health problem in the general population, associated with a substantial impact on quality of life and societal costs. However, many depressed patients in primary care do not receive the care they need. Reason for this is that pharmacotherapy is...

  • Two-year outcome of children treated for depression. Vostanis, P.; Feehan, C.; Grattan, E. // European Child & Adolescent Psychiatry;1998, Vol. 7 Issue 1, p12 

    Abstract Fifty-four children and adolescents (age 8-17) were assessed two years after a clinical intervention trial of cognitive-behavioural vs. non-focused treatment for depression. Eleven (20.4%) subjects fulfilled criteria for depression, while 21 (38.9%) reported significant depressive...

  • Treatment of adolescents with depression: the effect of transference interventions in a randomized controlled study of dynamic psychotherapy. Ulberg, Randi; Grete Hersoug, Anne; H›glend, Per // Trials;2012, Vol. 13 Issue 1, p159 

    Background: Depression in adolescents seems to be a growing problem that causes mental suffering and prevents young people from joining the workforce. There is also a high risk of relapse during adult life. There is emerging evidence for the effect of psychodynamic psychotherapy in adolescents....

  • The InterHerz project - a web-based psychological treatment for cardiac patients with depression: study protocol of a randomized controlled trial. Messerli-Brgy, Nadine; Barth, Jrgen; Berger, Thomas // Trials;2012, Vol. 13 Issue 1, p245 

    Background: Patients with heart disease often suffer from difficulties in psychological adaptation during cardiac rehabilitation. Mood disorders such as depression are known to be highly prevalent in cardiac patients and to have a negative impact on the progression of coronary heart disease....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics